Six-week tomato diet reduces liver fat marker in MASLD trial without weight loss

Optimistic presentation of preliminary findings with balanced caveats. Frames tomatoes as a 'familiar Mediterranean food with potential relevance' rather than a proven treatment, but leads with positive results.

Consumers with metabolic liver disease may gain access to a low-cost, accessible dietary intervention (tomato consumption) as a complementary management strategy, potentially reducing reliance on pharmaceutical interventions and improving health outcomes without requiring weight loss.

Potential for dietary guidelines to incorporate specific foods (tomatoes) into MASLD management protocols; possible expansion of insurance coverage for nutritional counseling; regulatory interest in functional food claims; opportunity for public health campaigns promoting Mediterranean diet components.